Skip to content
Disclosery

ORBIMED ADVISORS LLC: STTK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on STTK, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 6,306,127 STTK shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,306,127 shares
    Change vs previous 13F 0 shares

    0.83% of the 13F portfolio, value $43,764,521.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 6,306,127 shares
    Change vs previous 13F 0 shares

    0.88% of the 13F portfolio, value $40,548,397.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 6,306,127 shares
    Change vs previous 13F 0 shares

    0.47% of the 13F portfolio, value $23,017,364.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 6,306,127 shares
    Change vs previous 13F not available

    0.36% of the 13F portfolio, value $15,071,644.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).